We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DOW to Produce VORANOL WK5750 at Freeport Polyol Facility
Read MoreHide Full Article
Dow Inc. (DOW - Free Report) announced that VORANOL WK5750 will be produced at its Freeport polyol plant. VORANOL WK5750 is a cutting-edge polyether polyol that has a unique design and is expected to transform the comfort experience for products like mattresses and furniture.
This production will allow DOW to offer novel polyol options to meet the performance needs of its customers. VORANOL WK5750’s ability to serve as a powerful cell opener expands its utility to viscoelastic and high resiliency foam applications, marking DOW’s commitment to high application performance.
DOW is continuously making an effort to improve its flexible foam capabilities. VORANOL WK5750 has emerged as an enabler of specialty slabstock flexible foam applications by offering enhanced reactivity, optimal viscosity, a high standard of purity and quality, and an aesthetic appeal.
DOW shares have plunged 24.7% in the past year compared with a decline of 6.2% for its industry.
Image Source: Zacks Investment Research
Dow, on its third-quarter call, stated that it will continue to operate with discipline as it capitalizes on regions of strong demand while utilizing its global size and cost advantages. Its solid financials will continue to support its growth investments in higher-value industries and geographies, where it has a competitive cost advantage and sees strong demand. DOW anticipates these investments to generate more than $3 billion in underlying earnings by 2030.
DOW’s Zacks Rank and Key Picks
DOW currently carries a Zacks Rank #5 (Strong sell).
The Zacks Consensus Estimate for DD’s current-year earnings is pegged at $3.88, indicating a year-over-year rise of 11.5%. DD’s earnings beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 12.9%. The company’s shares have gained 15.7% in the past year.
The Zacks Consensus Estimate for Axalta Coating’s current year earnings is pegged at $2.15, indicating a rise of 36.9% from year-ago levels. The Zacks Consensus Estimate for AXTA’s current year earnings has increased 3.9% in the past 60 days. The stock has gained around 14% in the past year.
The Zacks Consensus Estimate for MEOH's current-year earnings is pegged at $3.21, indicating a year-over-year rise of 42.67%. MEOH beat the consensus estimate in each of the last four quarters, with the earnings surprise being 100.98%, on average.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
DOW to Produce VORANOL WK5750 at Freeport Polyol Facility
Dow Inc. (DOW - Free Report) announced that VORANOL WK5750 will be produced at its Freeport polyol plant. VORANOL WK5750 is a cutting-edge polyether polyol that has a unique design and is expected to transform the comfort experience for products like mattresses and furniture.
This production will allow DOW to offer novel polyol options to meet the performance needs of its customers. VORANOL WK5750’s ability to serve as a powerful cell opener expands its utility to viscoelastic and high resiliency foam applications, marking DOW’s commitment to high application performance.
DOW is continuously making an effort to improve its flexible foam capabilities. VORANOL WK5750 has emerged as an enabler of specialty slabstock flexible foam applications by offering enhanced reactivity, optimal viscosity, a high standard of purity and quality, and an aesthetic appeal.
DOW shares have plunged 24.7% in the past year compared with a decline of 6.2% for its industry.
Image Source: Zacks Investment Research
Dow, on its third-quarter call, stated that it will continue to operate with discipline as it capitalizes on regions of strong demand while utilizing its global size and cost advantages. Its solid financials will continue to support its growth investments in higher-value industries and geographies, where it has a competitive cost advantage and sees strong demand. DOW anticipates these investments to generate more than $3 billion in underlying earnings by 2030.
DOW’s Zacks Rank and Key Picks
DOW currently carries a Zacks Rank #5 (Strong sell).
Better-ranked stocks in the Basic Materials space are DuPont de Nemours, Inc. (DD - Free Report) , Axalta Coating Systems Ltd. (AXTA - Free Report) and Methanex Corporation (MEOH - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for DD’s current-year earnings is pegged at $3.88, indicating a year-over-year rise of 11.5%. DD’s earnings beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 12.9%. The company’s shares have gained 15.7% in the past year.
The Zacks Consensus Estimate for Axalta Coating’s current year earnings is pegged at $2.15, indicating a rise of 36.9% from year-ago levels. The Zacks Consensus Estimate for AXTA’s current year earnings has increased 3.9% in the past 60 days. The stock has gained around 14% in the past year.
The Zacks Consensus Estimate for MEOH's current-year earnings is pegged at $3.21, indicating a year-over-year rise of 42.67%. MEOH beat the consensus estimate in each of the last four quarters, with the earnings surprise being 100.98%, on average.